The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Przybyl Arthur since 2006.
The trader's CIK number is 1268135.
At the time of the last reporting, Przybyl Arthur was the President, CEO of Ani Pharmaceuticals Inc. (stock ticker symbol ANIP).
Also see all insider trading activities at Ani Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | AKRX | 0 | $0 | 0 | $0 | 1,221,258 | $2,696,537 |
| 2008 | AKRX | 0 | $0 | 273,002 | $930,166 | 261,666 | $594,802 |
| 2007 | AKRX | 0 | $0 | 0 | $0 | 75,000 | $63,750 |
| 2006 | AKRX | 0 | $0 | 300,000 | $0 | 300,000 | $330,000 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | ANIP | 0 | $0 | 27,625 | $1,754,959 | 0 | $0 |
| 2018 | ANIP | 0 | $0 | 63,986 | $3,956,729 | 39,709 | $739,224 |
| 2016 | ANIP | 0 | $0 | 37,455 | $2,508,361 | 69,624 | $915,028 |
| 2015 | ANIP | 2,500 | $102,375 | 75,000 | $4,725,000 | 15,000 | $95,400 |
| 2014 | ANIP | 1,000 | $26,500 | 0 | $0 | 0 | $0 |
2. Ani Pharmaceuticals Inc (ANIP)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-12-31 | AKRX | Option Ex | 1,221,258 | 2.21 | 2,696,537 |
| 2008-12-18 | AKRX | Option Ex | 54,688 | 2.23 | 121,680 |
| 2008-12-19 | AKRX | Option Ex | 62,144 | 2.23 | 138,394 |
| 2008-12-17 | AKRX | Option Ex | 32,789 | 2.24 | 73,480 |
| 2008-12-16 | AKRX | Option Ex | 42,852 | 2.30 | 98,645 |
| 2008-12-15 | AKRX | Option Ex | 69,193 | 2.35 | 162,603 |
| 2008-06-20 | AKRX | Sale | 251,850 | 3.41 | 859,815 |
| 2008-06-23 | AKRX | Sale | 21,152 | 3.33 | 70,351 |
| 2007-12-18 | AKRX | Option Ex | 75,000 | .85 | 63,750 |
| 2006-12-12 | AKN | Option Ex | 300,000 | 1.10 | 330,000 |
| 2006-12-12 | AKN | Sale | 300,000 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-03-18 | ANIP | Sale | 24,802 | 63.53 | 1,575,671 |
| 2019-03-19 | ANIP | Sale | 2,823 | 63.51 | 179,288 |
| 2018-03-12 | ANIP | Option Ex | 15,723 | 6.36 | 99,998 |
| 2018-03-13 | ANIP | Sale | 30,000 | 62.08 | 1,862,250 |
| 2018-03-14 | ANIP | Sale | 10,000 | 62.03 | 620,300 |
| 2018-03-01 | ANIP | Sale | 23,986 | 61.46 | 1,474,179 |
| 2018-03-01 | ANIP | Option Ex | 23,986 | 26.65 | 639,226 |
| 2016-08-22 | ANIP | Option Ex | 53,178 | 15.24 | 810,432 |
| 2016-08-22 | ANIP | Sale | 37,455 | 66.97 | 2,508,361 |
| 2016-01-08 | ANIP | Option Ex | 16,446 | 6.36 | 104,596 |
| 2015-11-12 | ANIP | Buy | 2,500 | 40.95 | 102,375 |
| 2015-08-10 | ANIP | Option Ex | 10,000 | 6.36 | 63,600 |
| 2015-05-07 | ANIP | Option Ex | 5,000 | 6.36 | 31,800 |
| 2015-03-12 | ANIP | Sale | 75,000 | 63.00 | 4,725,000 |
| 2014-09-09 | ANIP | Buy | 1,000 | 26.50 | 26,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Przybyl Arthur (President, CEO of Ani Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.